- President Donald Trump and Vice President Mike Pence had been major supporters of the “right-to-try” legislation, which would bypass drug regulators to give gravely ill patients access to experimental medicines.
- Proponents say this gives patients hope they would not otherwise have.
- Critics say the legislation undermines the FDA’s authority to regulate drugs and could leave patients vulnerable to medicines that might not work or may even be harmful.
Musk v. USAID: The Complicated Legacy of America’s Aid Agency
In 2026, the world’s first trillionaire—following the recent stock debut of SpaceX—Elon Musk has remained one of the most influential figures in American politics. After campaigning for Donald Trump in 2024 and initially playing a leading role in the Department of...
